In 1980 the DEA positioned P2P into Schedule II from the Managed Substances Act, which makes it illegal to order, sell, or possess with no managed material license. This is one of the earliest examples of the odd and unfortunate pattern of making pharmacologically inert substances unlawful since job criminals “could” misuse them. While P2P turn